insights_auto
Why is ONCY up 2,31%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
0,56 USD
arrow_upward
+2,31%(+0,013) 1D
0,55 USD
arrow_downward
-1,26% (-0,0070)bedtimeAfter hours
Closed: 9-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
0,55 USD
High
0,57 USD
Low
0,52 USD
Mkt. cap
73,03 млн
Avg. vol.
1,05 млн
Volume
1,46 млн
52-wk high
1,32 USD
52-wk low
0,52 USD
Beta
1,15
Shares outstanding
127,51 млн
No. of employees
29
Open
0,55 USD
High
0,57 USD
Low
0,52 USD
Mkt. cap
73,03 млн
Avg. vol.
1,05 млн
Volume
1,46 млн
52-wk high
1,32 USD
52-wk low
0,52 USD
Beta
1,15
Shares outstanding
127,51 млн
No. of employees
29
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 ай мурун
Oncolytics Biotech (ONCY) Holds Near $0.82 as Shares Edge Up 0.49% - Time Weighted Price
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc